Chromosomal Instability
Recent clinical, regulatory, research and industry developments relating to this disease.
The genomic landscape of 2,023 colorectal cancers.
Chromosomal Instability in Gastric Cancer: Role in Tumor Development, Progression, and Therapy.
Molecular Mechanisms of Colon Cancer Progression and Metastasis: Recent Insights and Advancements.
Pervasive chromosomal instability and karyotype order in tumour evolution.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
- 2 clinical trials with recent milestones.
- 1 industry development reported.
Clinical MilestonesViewHide
- 2026-06-01A Phase I/II Study of VLS-1488 (an Oral KIF18A Inhibitor) in Subjects With Advanced CancerPrimary completion
- 2026-03-01A Phase 1b Dose Optimization Study of Sovilnesib (an Oral KIF18A Inhibitor) in Subjects With Advanced High Grade Serous Ovarian CancerPrimary completion
Industry & MarketViewHide
- 2026-06-19Author Correction: Autophagic cell death restricts chromosomal instability during replicative crisisIndustry · Nature News
- 2026-06-19IndustryAuthor Correction: Autophagic cell death restricts chromosomal instability during replicative crisisIndustry · Nature News
- 2026-06-01ClinicalA Phase I/II Study of VLS-1488 (an Oral KIF18A Inhibitor) in Subjects With Advanced CancerPrimary completion
- 2026-03-01ClinicalA Phase 1b Dose Optimization Study of Sovilnesib (an Oral KIF18A Inhibitor) in Subjects With Advanced High Grade Serous Ovarian CancerPrimary completion
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes8
- Carcinoma, Renal Cell1
- Colorectal Neoplasms1
- Disease Progression1
- Epstein-Barr Virus Infections1
- Evolution, Molecular1
- Gene Expression Regulation, Neoplastic1
- Genetic Predisposition to Disease1
- Genome, Human1
Leading journals4
- International journal of molecular sciences2
- Nature2
- Cancer discovery1
- Nature cancer1
Leading researchers8
- Bakhoum SF2
- Litchfield K2
- Tomlinson IPM2
- Turajlic S2
- Al Moustafa AE1
- Alexandrov LB1
- Allouch A1
- Andre F1
Affiliations (unnormalised)6
- Memorial Sloan Kettering Cancer Center3
- The Francis Crick Institute2
- University College London Cancer Institute2
- Aarhus University Hospital1
- Berlin Institute for Medical Systems Biology1
- Big Data Institute1
Related conditions
Diseases frequently studied alongside this one. Number shows shared papers.
Disease profile
A grounded synthesis of the condition — overview, causes, mechanism, risk factors and current standard of care.
Chromosomal instability is an increased tendency for cells to acquire chromosome abnormalities when the processes that replicate, repair, or segregate chromosomes are dysfunctional. It is described in cancer literature as a feature of tumors with elevated rates of chromosomal instability and is associated with aneuploidies and structural chromosomal rearrangements. Micronuclei are a recognized manifestation of this state and are seen in human cancers.
The supplied material does not identify a single established cause. It indicates that chromosomal instability arises when chromosome replication, repair, or segregation processes are dysfunctional. In gastric cancer, the causes are described as still being under discussion.
The core mechanism is failure of chromosome maintenance, leading to chromosome aberrations, mis-segregation, aneuploidy, and structural rearrangements. Chromosome-containing micronuclei can form from mis-segregated chromosomes and are linked to elevated chromosomal instability. The literature also connects chromosomal instability with DNA copy number variations and loss of heterozygosity.
The supplied grounding does not support general risk factors for chromosomal instability as a standalone disease entity. In cancer contexts, it is associated with tumors that show chromosome mis-segregation and micronuclei formation, but no broader risk factors are provided.
No standard treatment for chromosomal instability itself is supported in the supplied material. The reviews describe it as a tumor feature or subtype relevant to cancer progression, biomarker development, and therapeutic targeting, rather than a condition with a direct disease-specific treatment. In the cited cancer contexts, management is discussed at the level of cancer therapies and molecular targeting, but no specific standard-of-care modality for chromosomal instability is established here.
AI-generated summary grounded in MeSH and 3 peer-reviewed sources. Informational only — not medical advice. Generated 2026-07-07.
Reference
Authoritative identity, definition & identifiers.
An increased tendency to acquire CHROMOSOME ABERRATIONS when various processes involved in chromosome replication, repair, or segregation are dysfunctional.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.